Results 91 to 100 of about 6,218 (156)

Patterns of use of oral antivirals for COVID-19 in people 70 years and over in Victoria, Australia: a linked data study. [PDF]

BMC Infect Dis
Edwards LJ, Scaria A, Cheng AC, Amin J, Robinson EJ, Sumpton C, Liu B.   +6 more
europepmc   +1 more source

Targeting SARS-CoV-2 main protease (3CL^pro) with Paeonia-derived phytochemicals. [PDF]

In Silico Pharmacol
Sandalli C, Bostancioglu SM, Sandalli A, Turumtay EA, Almohazey D, Alsaeed M, Alhamid G, Rabaan AA, Turumtay H, Ami EI, Lorson CL, Hannink M, Singh K, Tombuloglu H.   +13 more
europepmc   +1 more source

COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study. [PDF]

Interact J Med Res
Kueper JK, Kottilil K, Quer G, Chiang DC, Spencer EG, Purushotham J, Ramos E, Roumani L, Andersen KG, Topol EJ, Pandit JA, Mina MJ.   +11 more
europepmc   +1 more source

Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants. [PDF]

JACS Au
Cai Z, Kohaal N, Georgiou K, Liang X, Chi X, Tan H, Tan B, Li K, Fan G, Lambrinidis G, Kolocouris A, Deng X, Chen Y, Wang J.   +13 more
europepmc   +1 more source

Profound Synergistic Bradycardia: Pharmacokinetic Consequences of Paxlovid-Mediated CYP3A4 and CYP2D6 Inhibition on Ranolazine, Diltiazem, and Metoprolol. [PDF]

Cureus
Bactawar SB, Gaibor C, Abdul-Waheed M.
europepmc   +1 more source

Cell-Based Luciferase Assay for Testing SARS-CoV-2 3CL Protease Inhibitors. [PDF]

Biosensors (Basel)
Shcherbakov DN, Mordvinova ED, Trufanov VO, Volkova NV, Meshkova YV, Marenina MK, Zaykovskaya AV, Volosnikova EA, Borisevich SS, Belenkaya SV.   +9 more
europepmc   +1 more source

Viral kinetics in adults with Covid-19 treated with nirmatrelvir-ritonavir or molnupiravir: a population-based, observational cohort study. [PDF]

Virol J
Prager M, Ensle D, Eser H, Glötzl F, Riedl B, Szell M, Valipour A, Zoufaly A, Wenisch C, Haider D, Burgmann H, Thalhammer F, Götzinger F, Jilma B, Karnthaler U, Zeitlinger M, Jorda A.   +16 more
europepmc   +1 more source

Pharmacokinetics, pathology and efficacy of SARS-CoV-2 main protease inhibitor VPC285785 in a murine model of coronavirus infection. [PDF]

Sci Rep
Smith JR, Toro A, Sabater A, Kovacic S, Ban F, Arevalo AP, Crispo M, Gueron G, Young RN, Cherkasov A.   +9 more
europepmc   +1 more source

Vaccination and Antiviral Combination Improves Resolution Time of COVID-19 Infection in Treated Multiple Myeloma: A Retrospective Study. [PDF]

Adv Hematol
Di Cecca M, V B, M G, F F, V T, G B, C L, A R, B R, S R, F P, L P, L F, M T T, B A, L C, E S, F F, T CDT, A M Q, S P, M L, A T, A P, M T P, L R, O A.   +26 more
europepmc   +1 more source

Nirmatrelvir/Ritonavir-Induced Calcium Channel Blocker Intoxication Successfully Treated by High Dose Insulin Therapy. [PDF]

Acta Cardiol Sin
Chen CY, Cia CT.
europepmc   +1 more source